FTC Wants To Extend Actavis To Authorized Generics Deals
By Melissa Lipman ( August 16, 2013, 7:05 PM EDT) -- The Federal Trade Commission on Wednesday urged a New Jersey federal judge overseeing private antitrust litigation targeting an authorized generics deal between Wyeth LLC and Teva Pharmaceuticals USA Inc. to apply the U.S. Supreme Court's recent pay-for-delay ruling to the case....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.